{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P05113",
      "entity_text" : "IL-5",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P01215",
      "entity_text" : "CgA",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Thus, CgA peptides reduce the release of interleukin (IL) -16 and IL-5, with the reduction of the number of lymphocytes at the sites inflammation and hence the pro inflammatory action of lymphocytes and monocytes.",
  "reading_complete" : "2020-08-03T14:35:21Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T14:33:40Z",
  "trigger" : "reduce",
  "evidence" : [ "CgA peptides reduce the release of interleukin (IL)-16 and IL-5" ],
  "pmc_id" : "4771106",
  "score" : 0
}